Fungi in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis

Abstract

Bronchiectasis is a pathologic bronchial dilatation with loss of function that can result from multiple inflammatory and infectious injuries to the conducting airways of the lung. Molds, particularly the filamentous fungus Aspergillus fumigatus, have been implicated as a common cause of both cystic fibrosis (CF) and non-CF bronchiectasis, the latter primarily in patients with severe asthma. The pathogenesis of mold-associated bronchiectasis is usually due to atopic sensitization to mold allergens in the presence of active chronic endobronchial fungal infection with host innate and adaptive immune deviation to a Th2-dominated inflammation, a condition known as allergic bronchopulmonary aspergillosis (ABPA) (or allergic bronchopulmonary mycosis if a non-Aspergillus mold is implicated). Diagnostic criteria of ABPA continue to evolve, while treatment relies upon downregulation of the allergic inflammatory response with immunomodulatory agents and antifungal pharmacotherapy.

Keywords

bronchiectasis - cystic fibrosis - Aspergillus fumigatus - allergic bronchopulmonary aspergillosis - allergic bronchopulmonary mycosis

• References

• 1 Barker AF. Bronchiectasis. N Engl J Med 2002; 346 (18) 1383-1393
• 2 O'Donnell AE. Bronchiectasis. Chest 2008; 134 (4) 815-823
• 3 Naidich DP, McCauley DI, Khouri NF, Stitik FP, Siegelman SS. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982; 6 (3) 437-444
• 4 Bonavita J, Naidich DP. Imaging of bronchiectasis. Clin Chest Med 2012; 33 (2) 233-248
• 5 Hill AT, Pasteur M, Cornford C, Welham S, Bilton D. Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J 2011; 20 (2) 135-140
• 6 King P, Holdsworth S, Freezer N, Holmes P. Bronchiectasis. Intern Med J 2006; 36 (11) 729-737
• 7 McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2013; 188 (6) 647-656
• 8 Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots R. Trends in bronchiectasis among Medicare beneficiaries in the United States, 2000 to 2007. Chest 2012; 142 (2) 432-439
• 9 Pasteur MC, Helliwell SM, Houghton SJ , et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000; 162 (4, Pt 1): 1277-1284
• 10 Cole PJ. Inflammation: a two-edged sword—the model of bronchiectasis. Eur J Respir Dis Suppl 1986; 147: 6-15
• 11 Whitters D, Stockley R. Immunity and bacterial colonisation in bronchiectasis. Thorax 2012; 67 (11) 1006-1013
• 12 Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 2008; 14 (6) 595-599
• 13 Wickremasinghe M, Ozerovitch LJ, Davies G , et al. Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 2005; 60 (12) 1045-1051
• 14 Knutsen AP, Bush RK, Demain JG , et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012; 129 (2) 280-291, quiz 292–293
• 15 Tunney MM, Einarsson GG, Wei L , et al. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med 2013; 187 (10) 1118-1126
• 16 Rogers GB, van der Gast CJ, Cuthbertson L , et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax 2013; 68 (8) 731-737
• 17 Agarwal R, Chakrabarti A, Shah A , et al; ABPA complicating asthma ISHAM working group. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013; 43 (8) 850-873
• 18 Delhaes L, Monchy S, Fréalle E , et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community—implications for therapeutic management. PLoS ONE 2012; 7 (4) e36313
• 19 Mounier J, Gouëllo A, Keravec M , et al. Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients. J Microbiol 2014; 52 (4) 307-314
• 20 Harrison MJ, Twomey KB, McCarthy Y , et al. The role of second-generation sequencing in describing the fungal microbiota in the adult cystic fibrosis airway and its correlation with clinical phenotype. [Abstract] J Cyst Fibros 2013; 12 (Suppl): S16
• 21 Moss RB. Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis. Eur Respir J 2014; 43 (5) 1487-1500
• 22 Kwon-Chung KJ, Sugui JA. Aspergillus fumigatus—what makes the species a ubiquitous human fungal pathogen?. PLoS Pathog 2013; 9 (12) e1003743
• 23 Chotirmall SH, Mirkovic B, Lavelle GM, McElvaney NG. Immunoevasive Aspergillus virulence factors. Mycopathologia 2014; 178 (5-6) 363-370
• 24 Chowdhary A, Agarwal K, Kathuria S, Gaur SN, Randhawa HS, Meis JF. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol 2014; 40 (1) 30-48
• 25 Ishiguro T, Takayanagi N, Kagiyama N, Shimizu Y, Yanagisawa T, Sugita Y. Clinical characteristics of biopsy-proven allergic bronchopulmonary mycosis: variety in causative fungi and laboratory findings. Intern Med 2014; 53 (13) 1407-1411
• 26 Matsuse H, Tsuchida T, Fukahori S , et al. Dissociation between sensitizing and colonizing fungi in patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 2013; 111 (3) 190-193
• 27 Tashiro T, Izumikawa K, Tashiro M , et al. Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward. Med Mycol 2011; 49 (6) 581-587
• 28 Shah A, Maurya V, Panjabi C, Khanna P. Allergic bronchopulmonary aspergillosis without clinical asthma caused by Aspergillus niger. Allergy 2004; 59 (2) 236-237
• 29 Al-Mobeireek AF, Al-Hedaithy SS, Alasali K, Al-Majed S, Joharjy I ; El-Rab MOGAD. Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia. Respir Med 2001; 95 (5) 341-347
• 30 Hoshino H, Tagaki S, Kon H , et al. Allergic bronchopulmonary aspergillosis due to Aspergillus niger without bronchial asthma. Respiration 1999; 66 (4) 369-372
• 31 Shimada T, Matsumura K. [A case of probable allergic bronchopulmonary aspergillosis due to Aspergillus niger]. Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33 (3) 336-341
• 32 Sandhu RS, Mehta SK, Khan ZU, Singh MM. Role of Aspergillus and Candida species in allergic bronchopulmonary mycoses. A comparative study. Scand J Respir Dis 1979; 60 (5) 235-242
• 33 Oshima M, Soda H, Oda H, Watanabe A. A case of allergic bronchopulmonary aspergillosis caused by Aspergillus terreus [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35 (12) 1418-1424
• 34 Nakahara Y, Katoh O, Yamada H, Sumida I, Hanada M. Allergic bronchopulmonary aspergillosis caused by Aspergillus terreus presenting lobar collapse. Intern Med 1992; 31 (1) 140-142
• 35 Vincken W, Schandevul W, Roels P. Allergic bronchopulmonary aspergillosis caused by Aspergillus terreus. Am Rev Respir Dis 1983; 127 (3) 388-389
• 36 Yamamoto K, Abe M, Inoue Y, Yokoyama A, Kohno N, Hiwada K. Development of infection with Aspergillus flavus in woman being treated for allergic pulmonary Aspergillosis caused by Aspergillus fumigatus [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1995; 33 (10) 1099-1104
• 37 Novey HS, Wells ID. Allergic bronchopulmonary aspergillosis caused by Aspergillus ochraceus. Am J Clin Pathol 1978; 70 (5) 840-843
• 38 Poole CJ, Wong M. Allergic bronchopulmonary aspergillosis in garden waste (compost) collectors—occupational implications. Occup Med (Lond) 2013; 63 (7) 517-519
• 39 Kurosawa M, Kobayashi S, Yanagihara Y, Shida T. A case of occupational allergic bronchopulmonary aspergillosis unique to Japan. Br J Clin Pract 1990; 44 (11) 482-489
• 40 Akiyama K, Takizawa H, Suzuki M, Miyachi S, Ichinohe M, Yanagihara Y. Allergic bronchopulmonary aspergillosis due to Aspergillus oryzae. Chest 1987; 91 (2) 285-286
• 41 Kino T, Chihara J, Mitsuyasu K , et al. A case of allergic bronchopulmonary aspergillosis caused by Aspergillus oryzae which is used for brewing bean paste (miso) and soy sauce (shoyu) (author's transl) [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1982; 20 (4) 467-475
• 42 Boucher RC. Bronchiectasis: a continuum of ion transport dysfunction or multiple hits?. Am J Respir Crit Care Med 2010; 181 (10) 1017-1019
• 43 Bienvenu T, Sermet-Gaudelus I, Burgel PR , et al. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010; 181 (10) 1078-1084
• 44 Gonska T, Choi P, Stephenson A , et al. Role of cystic fibrosis transmembrane conductance regulator in patients with chronic sinopulmonary disease. Chest 2012; 142 (4) 996-1004
• 45 Chaudhary N, Datta K, Askin FB, Staab JF, Marr KA. Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. Am J Respir Crit Care Med 2012; 185 (3) 301-310
• 46 Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol 2006; 177 (8) 5186-5194
• 47 Müller C, Braag SA, Herlihy JD , et al. Enhanced IgE allergic response to Aspergillus fumigatus in CFTR-/- mice. Lab Invest 2006; 86 (2) 130-140
• 48 Mueller C, Braag SA, Keeler A, Hodges C, Drumm M, Flotte TR. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am J Respir Cell Mol Biol 2011; 44 (6) 922-929
• 49 Rapaka RR, Kolls JK. Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med Mycol 2009; 47 (Suppl. 01) S331-S337
• 50 Eickmeier O, Rieber N, Eckrich J, Hector A, Graeppler-Mainka U, Hartl D. Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease. Curr Pharm Des 2013; 19 (20) 3669-3678
• 51 Chotirmall SH, Al-Alawi M, Mirkovic B , et al. Aspergillus-associated airway disease, inflammation, and the innate immune response. Biomed Res Int 2013; 2013: 723129
• 52 Sabino R, Ferreira JA, Moss RB , et al. Molecular epidemiology of Aspergillus collected from cystic fibrosis patients. J Cyst Fibros 2014; ; doi: 10.1016/j.jcf.2014.10.005 [E-pub ahead of print]
• 53 Baxter CG, Dunn G, Jones AM , et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol 2013; 132 (3) 560-566.e10
• 54 Armstead J, Morris J, Denning DW. Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis. PLoS ONE 2014; 9 (6) e98502
• 55 Nicolai T, Arleth S, Spaeth A, Bertele-Harms RM, Harms HK. Correlation of IgE antibody titer to Aspergillus fumigatus with decreased lung function in cystic fibrosis. Pediatr Pulmonol 1990; 8 (1) 12-15
• 56 Wojnarowski C, Eichler I, Gartner C , et al. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997; 155 (6) 1902-1907
• 57 Kanthan SK, Bush A, Kemp M, Buchdahl R. Factors effecting impact of Aspergillus fumigatus sensitization in cystic fibrosis. Pediatr Pulmonol 2007; 42 (9) 785-793
• 58 Fillaux J, Brémont F, Murris M , et al. Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. Scand J Infect Dis 2012; 44 (11) 842-847
• 59 Baxter CG, Moore CB, Jones AM, Webb AK, Denning DW. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest 2013; 143 (5) 1351-1357
• 60 Peetermans M, Goeminne P, De Boeck C, Dupont LJ. IgE sensitization to Aspergillus fumigatus is not a bystander phenomenon in cystic fibrosis lung disease. Chest 2014; 146 (3) e99-e100
• 61 Kraemer R, Deloséa N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2006; 174 (11) 1211-1220
• 62 Chotirmall SH, McElvaney NG. Fungi in the cystic fibrosis lung: bystanders or pathogens?. Int J Biochem Cell Biol 2014; 52: 161-173
• 63 Parize P, Billaud S, Bienvenu AL , et al. Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. J Cyst Fibros 2014; 13 (6) 667-673
• 64 Kondori N, Lindblad A, Welinder-Olsson C, Wennerås C, Gilljam M. Development of IgG antibodies to Exophiala dermatitidis is associated with inflammatory responses in patients with cystic fibrosis. J Cyst Fibros 2014; 13 (4) 391-399
• 65 Barenfanger J, Ramirez F, Tewari RP, Eagleton L. Pulmonary phaeohyphomycosis in a patient with hemoptysis. Chest 1989; 95 (5) 1158-1160
• 66 Mukaino T, Koga T, Oshita Y, Narita Y, Obata S, Aizawa H. Exophiala dermatitidis infection in non-cystic fibrosis bronchiectasis. Respir Med 2006; 100 (11) 2069-2071
• 67 Ozawa Y, Suda T, Kaida Y , et al. [A case of bronchial infection of Wangiella dermatitidis]. Nihon Kokyuki Gakkai Zasshi 2007; 45 (11) 907-911
• 68 Murayama T, Amitani R, Tsuyuguchi K , et al. Polypoid bronchial lesions due to Scedosporium apiospermum in a patient with Mycobacterium avium complex pulmonary disease. Eur Respir J 1998; 12 (3) 745-747
• 69 Greig JR, Khan MA, Hopkinson NS, Marshall BG, Wilson PO, Rahman SU. Pulmonary infection with Scedosporium prolificans in an immunocompetent individual. J Infect 2001; 43 (1) 15-17
• 70 Stick SM, Brennan S, Murray C , et al; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155 (5) 623-8.e1
• 71 Sly PD, Brennan S, Gangell C , et al; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009; 180 (2) 146-152
• 72 Mott LS, Park J, Murray CP , et al; AREST CF. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012; 67 (6) 509-516
• 73 Sly PD, Gangell CL, Chen L , et al; AREST CF Investigators. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 2013; 368 (21) 1963-1970
• 74 Goffard A, Lambert V, Salleron J , et al. Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients. J Clin Virol 2014; 60 (2) 147-153
• 75 LiPuma JJ. Expanding our understanding of respiratory microbiota in cystic fibrosis. Ann Am Thorac Soc 2014; 11 (7) 1084-1085
• 76 Ramsey KA, Ranganathan S, Park J , et al; AREST CF. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med 2014; 190 (10) 1111-1116
• 77 McMahon MA, Chotirmall SH, McCullagh B, Branagan P, McElvaney NG, Logan PM. Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. Eur J Radiol 2012; 81 (3) e197-e202
• 78 Reihill JA, Moore JE, Elborn JS, Ennis M. Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium. J Cyst Fibros 2011; 10 (6) 401-406
• 79 Kapur N, Grimwood K, Masters IB, Morris PS, Chang AB. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol 2012; 47 (3) 300-307
• 80 Ward S, Heyneman L, Lee MJ, Leung AN, Hansell DM, Müller NL. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 1999; 173 (4) 937-942
• 81 Angus RM, Davies ML, Cowan MD, McSharry C, Thomson NC. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus . Thorax 1994; 49 (6) 586-589
• 82 Eaton T, Garrett J, Milne D, Frankel A, Wells AU. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest 2000; 118 (1) 66-72
• 83 Fairs A, Agbetile J, Hargadon B , et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010; 182 (11) 1362-1368
• 84 Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy 2011; 66 (5) 679-685
• 85 Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27 (3) 615-626
• 86 Agbetile J, Fairs A, Desai D , et al. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy 2012; 42 (5) 782-791
• 87 Heaney LG, Conway E, Kelly C , et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003; 58 (7) 561-566
• 88 Reese TA, Liang HE, Tager AM , et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007; 447 (7140) 92-96
• 89 Van Dyken SJ, Garcia D, Porter P , et al. Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration. J Immunol 2011; 187 (5) 2261-2267
• 90 Neveu WA, Bernardo E, Allard JL , et al. Fungal allergen β-glucans trigger p38 mitogen-activated protein kinase-mediated IL-6 translation in lung epithelial cells. Am J Respir Cell Mol Biol 2011; 45 (6) 1133-1141
• 91 Amitani R, Taylor G, Elezis EN , et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 1995; 63 (9) 3266-3271
• 92 Carrion SdeJ, Leal Jr SM, Ghannoum MA, Aimanianda V, Latgé JP, Pearlman E. The RodA hydrophobin on Aspergillus fumigatus spores masks dectin-1- and dectin-2-dependent responses and enhances fungal survival in vivo. J Immunol 2013; 191 (5) 2581-2588
• 93 Oosthuizen JL, Gomez P, Ruan J , et al. Dual organism transcriptomics of airway epithelial cells interacting with conidia of Aspergillus fumigatus . PLoS ONE 2011; 6 (5) e20527
• 94 Grimm MJ, Vethanayagam RR, Almyroudis NG , et al. Monocyte- and macrophage-targeted NADPH oxidase mediates antifungal host defense and regulation of acute inflammation in mice. J Immunol 2013; 190 (8) 4175-4184
• 95 Park SJ, Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev 2009; 22 (4) 535-551
• 96 Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 2011; 29: 1-21
• 97 Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 2014; 14 (6) 405-416
• 98 Kreindler JL, Steele C, Nguyen N , et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest 2010; 120 (9) 3242-3254
• 99 Becker KL, Gresnigt MS, Smeekens SP , et al. Pattern recognition pathways leading to a Th2 cytokine bias in ABPA patients. Clin Exp Allergy 2015; 45 (2) 423-437
• 100 Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11 (4) 275-288
• 101 Wark PA, Saltos N, Simpson J, Slater S, Hensley MJ, Gibson PG. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 2000; 16 (6) 1095-1101
• 102 Gibson PG, Wark PA, Simpson JL , et al. Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J 2003; 21 (4) 582-588
• 103 Fei M, Bhatia S, Oriss TB , et al. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc Natl Acad Sci U S A 2011; 108 (13) 5360-5365
• 104 Porter PC, Lim DJ, Maskatia ZK , et al. Airway surface mycosis in chronic TH2-associated airway disease. J Allergy Clin Immunol 2014; 134 (2) 325-331
• 105 Homma T, Bhushan B, Kato A , et al. Aspergillus fumigatus may promote Th2 activation by suppression of interferon signaling. [abstract] J Allergy Clin Immunol 2014; 133 (2, Suppl): AB136
• 106 Hartl D, Buckland KF, Hogaboam CM. Chemokines in allergic aspergillosis—from animal models to human lung diseases. Inflamm Allergy Drug Targets 2006; 5 (4) 219-228
• 107 Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002; 169 (10) 5904-5911
• 108 Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004; 114 (5) 997-1008 , quiz 1009
• 109 Porter P, Susarla SC, Polikepahad S , et al. Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol 2009; 2 (6) 504-517
• 110 Porter PC, Yang T, Luong A , et al. Proteinases as molecular adjuvants in allergic airway disease. Biochim Biophys Acta 2011; 1810 (11) 1059-1065
• 111 Namvar S, Warn P, Farnell E, Bromley M, Bowyer P, Herrick S. Aspergillus fumigatus proteases, Asp f 5 and Asp f 13, are essential for airway inflammation and remodelling in a murine inhalation model. Clin Exp Allergy 2014; . doi: 10.1111/cea. 12426 [e-Pub ahead of print]
• 112 Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS ONE 2010; 5 (12) e15346
• 113 Agarwal R, Khan A, Garg M, Aggarwal AN, Gupta D. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol 2012; 4 (4) 141-150
• 114 Oguma T, Asano K, Tomomatsu K , et al. Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells. J Immunol 2011; 187 (2) 999-1005
• 115 Fahy JV, Schuster A, Ueki I, Boushey HA, Nadel JA. Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases. Am Rev Respir Dis 1992; 146 (6) 1430-1433
• 116 Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 2013; 51 (4) 361-370
• 117 Leclair LW, Hogan DA. Mixed bacterial-fungal infections in the CF respiratory tract. Med Mycol 2010; 48 (Suppl. 01) S125-S132
• 118 Tomlinson JR, Sahn SA. Aspergilloma in sarcoid and tuberculosis. Chest 1987; 92 (3) 505-508
• 119 Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 2011; 89 (12) 864-872
• 120 Dhooria S, Kumar P, Saikia B , et al. Prevalence of Aspergillus sensitisation in pulmonary tuberculosis-related fibrocavitary disease. Int J Tuberc Lung Dis 2014; 18 (7) 850-855
• 121 Moore EH. Atypical mycobacterial infection in the lung: CT appearance. Radiology 1993; 187 (3) 777-782
• 122 Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J 2006; 28 (2) 352-357
• 123 Levy I, Grisaru-Soen G, Lerner-Geva L , et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 2008; 14 (3) 378-384
• 124 Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 2005; 25 (2) 324-328
• 125 Harris JK, Zemanick ET. Microbes in bronchiectasis: the forest or the trees?. Am J Respir Crit Care Med 2013; 187 (10) 1044-1045
• 126 Greene R. The pulmonary aspergilloses: three distinct entities or a spectrum of disease. Radiology 1981; 140 (2) 527-530
• 127 Buckingham SJ, Hansell DM. Aspergillus in the lung: diverse and coincident forms. Eur Radiol 2003; 13 (8) 1786-1800
• 128 Chrdle A, Mustakim S, Bright-Thomas RJ, Baxter CG, Felton T, Denning DW. Aspergillus bronchitis without significant immunocompromise. Ann N Y Acad Sci 2012; 1272: 73-85
• 129 Shah A, Panjabi C. Allergic aspergillosis of the respiratory tract. Eur Respir Rev 2014; 23 (131) 8-29
• 130 Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax 2014; . doi: 10.1136/thoraxjnl-2014-206291 [E-pub ahead of print]
• 131 Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986; 146 (5) 916-918
• 132 Greenberger PA, Miller TP, Roberts M, Smith LL. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 1993; 70 (4) 333-338
• 133 Agarwal R, Garg M, Aggarwal AN, Saikia B, Gupta D, Chakrabarti A. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes. Respir Med 2012; 106 (7) 942-947
• 134 Moss RB. Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis. Curr Opin Pulm Med 2010; 16 (6) 598-603
• 135 Agarwal R, Aggarwal AN, Garg M, Saikia B, Gupta D, Chakrabarti A. Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome. Mycopathologia 2012; 174 (3) 193-201
• 136 Chung Y, Kraut JR, Stone AM, Valaitis J. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis. Pediatr Pulmonol 1994; 17 (2) 131-134
• 137 Ganassini A, Cazzadori A. Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis. Respir Med 1995; 89 (2) 143-145
• 138 Massam J, Bitnun A, Solomon M , et al. Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature. Pediatr Infect Dis J 2011; 30 (2) 178-180
• 139 Mosquera RA, Estrada L, Clements RM, Jon CK. Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis. BMJ Case Rep 2013; 2013
• 140 Stevens DA, Moss RB, Kurup VP , et al; Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 (Suppl. 03) S225-S264
• 141 Agarwal R, Maskey D, Aggarwal AN , et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS ONE 2013; 8 (4) e61105
• 142 Agarwal R, Aggarwal AN, Garg M, Saikia B, Chakrabarti A. Cut-off values of serum IgE (total and A. fumigatus -specific) and eosinophil count in differentiating allergic bronchopulmonary aspergillosis from asthma. Mycoses 2014; 57 (11) 659-663
• 143 Gernez Y, Dunn CE, Everson C , et al. Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by Aspergillus allergens. J Cyst Fibros 2012; 11 (6) 502-510
• 144 Moss RB. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis. Ann N Y Acad Sci 2012; 1272: 49-57
• 145 Wong R, Wong M, Robinson PD, Fitzgerald DA. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis. Paediatr Respir Rev 2013; 14 (1) 22-24
• 146 Homma T, Kurokawa M, Matsukura S, Yamaguchi M, Adachi M. Anti-IgE therapy for allergic bronchopulmonary aspergillosis. J Microbiol Immunol Infect 2013; . doi: 10.1016/j.jmii.2013.10.003 [E-pub ahead of print]
• 147 Tanou K, Zintzaras E, Kaditis AG. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence. Pediatr Pulmonol 2014; 49 (5) 503-507
• 148 Zicari AM, Celani C, De Castro G, Valerio De Biase R, Duse M. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. Eur Rev Med Pharmacol Sci 2014; 18 (13) 1839-1841
• 149 Lehmann S, Pfannenstiel C, Friedrichs F, Kröger K, Wagner N, Tenbrock K. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Ther Adv Respir Dis 2014; 8 (5) 141-149
• 150 Moss RB. Critique of trials in allergic bronchopulmonary aspergilllosis and fungal allergy. Med Mycol 2006; 44 (Suppl. 01) S269-S272
• 151 Moss RB. Management of allergic aspergillosis. Curr Fungal Infect Reports 2008; 2 (2) 87-93
• 152 Moreira AS, Silva D, Ferreira AR, Delgado L. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. Clin Exp Allergy 2014; 44 (10) 1210-1227
• 153 Chishimba L, Langridge P, Powell G, Niven RM, Denning DW. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). J Asthma 2014; 23: 1-7
• 154 Sehgal IS, Agarwal R. Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis. J Postgrad Med 2014; 60 (1) 41-45
• 155 Denning DW, Pashley C, Hartl D , et al. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy 2014; 4: 14